top of page
Untitled design-7.png
Are you living with ATTR?

You may qualify to participate in an opportunity to share your feedback about your experiences! 

We are inviting people who have been diagnosed with transthyretin-mediated amyloidosis (ATTR) to participate in a 90-minute online journal exercise. The purpose of the journal is to gain feedback on people's experiences with treatment for ATTR.


Those who qualify for and complete an activity will receive $200 as a thank you. 

ATTR Pinpoint Virtual Research Study.jpg
bottom of page